- Home
- ATPC vs OGEN Comparison
ATPC vs OGEN Comparison
Compare ATPC & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATPC
- OGEN
- Stock Information
- Founded
- ATPC 2016
- OGEN 1996
- Country
- ATPC Malaysia
- OGEN United States
- Employees
- ATPC N/A
- OGEN N/A
- Industry
- ATPC Medical/Nursing Services
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ATPC Health Care
- OGEN Health Care
- Exchange
- ATPC Nasdaq
- OGEN Nasdaq
- Market Cap
- ATPC 5.2M
- OGEN 4.6M
- IPO Year
- ATPC N/A
- OGEN N/A
- Fundamental
- Price
- ATPC $1.28
- OGEN $0.21
- Analyst Decision
- ATPC
- OGEN
- Analyst Count
- ATPC 0
- OGEN 0
- Target Price
- ATPC N/A
- OGEN N/A
- AVG Volume (30 Days)
- ATPC 68.3K
- OGEN 340.9K
- Earning Date
- ATPC 05-13-2025
- OGEN 05-14-2025
- Dividend Yield
- ATPC N/A
- OGEN N/A
- EPS Growth
- ATPC N/A
- OGEN N/A
- EPS
- ATPC N/A
- OGEN N/A
- Revenue
- ATPC $1,322,747.00
- OGEN N/A
- Revenue This Year
- ATPC N/A
- OGEN N/A
- Revenue Next Year
- ATPC N/A
- OGEN N/A
- P/E Ratio
- ATPC N/A
- OGEN N/A
- Revenue Growth
- ATPC N/A
- OGEN N/A
- 52 Week Low
- ATPC $0.90
- OGEN $0.19
- 52 Week High
- ATPC $8.00
- OGEN $3.43
- Technical
- Relative Strength Index (RSI)
- ATPC 82.65
- OGEN 26.93
- Support Level
- ATPC $1.02
- OGEN $0.19
- Resistance Level
- ATPC $1.32
- OGEN $0.22
- Average True Range (ATR)
- ATPC 0.09
- OGEN 0.02
- MACD
- ATPC 0.08
- OGEN -0.01
- Stochastic Oscillator
- ATPC 78.95
- OGEN 15.11
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.